Talaris Therapeutics Company
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies.
Technology:
Cell therapy
Industry:
Cell Therapy, Public
Headquarters:
Wellesley, Massachusetts, United States
Founded Date:
2002-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
14
Total Funding:
215000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-10-06
Last Funding Type:
Series B
Register and Claim Ownership